BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 26346367)

  • 1. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 Inhibitors.
    Wang PF; Qiu HY; Baloch SK; Gong HB; Wang ZC; Zhu HL
    Chem Biol Drug Des; 2015 Dec; 86(6):1405-10. PubMed ID: 26061284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
    Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
    Huang RZ; Liang GB; Huang XC; Zhang B; Zhou MM; Liao ZX; Wang HS
    Eur J Med Chem; 2017 Sep; 138():979-992. PubMed ID: 28756264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydropyrazothiazole derivatives as potential MMP-2/MMP-8 inhibitors for cancer therapy.
    Wang ZC; Shen FQ; Yang MR; You LX; Chen LZ; Zhu HL; Lu YD; Kong FL; Wang MH
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3816-3821. PubMed ID: 30342958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.
    Adhikari N; Halder AK; Mallick S; Saha A; Saha KD; Jha T
    Bioorg Med Chem; 2016 Sep; 24(18):4291-4309. PubMed ID: 27452283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyrazole Derivatives Containing Benzo Oxygen Heterocycle and Sulfonamide Moieties Selectively and Potently Inhibit COX-2: Design, Synthesis, and Anti-Colon Cancer Activity Evaluation.
    Yan XQ; Wang ZC; Zhang B; Qi PF; Li GG; Zhu HL
    Molecules; 2019 Apr; 24(9):. PubMed ID: 31052167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
    Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W
    Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.
    Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB
    Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Activity Relationships of UTX-121 Derivatives for the Development of Novel Matrix Metalloproteinase-2/9 Inhibitors.
    Yamahana H; Komiya Y; Takino T; Endo Y; Yamada H; Asada C; Uto Y
    Chem Pharm Bull (Tokyo); 2021; 69(10):1017-1028. PubMed ID: 34602570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of Novel Hybrids Inspired from Bromopyrrole Alkaloids Inhibiting MMP-2 and -12 as Antineoplastic Agents.
    Rane RA; Naphade SS; Bangalore PK; Palkar MB; Patel HM; Shaikh MS; Alwan WS; Karpoormath R
    Chem Biol Drug Des; 2015 Aug; 86(2):210-22. PubMed ID: 25418204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, crystal structure and effect of indeno[1,2-b]indole derivatives on prostate cancer in vitro. Potential effect against MMP-9.
    Lobo G; Monasterios M; Rodrigues J; Gamboa N; Capparelli MV; Martínez-Cuevas J; Lein M; Jung K; Abramjuk C; Charris J
    Eur J Med Chem; 2015; 96():281-95. PubMed ID: 25899333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matrix metalloproteinase (MMP) inhibitors.
    Chen C; Yang X; Fang H; Hou X
    Eur J Med Chem; 2019 Nov; 181():111563. PubMed ID: 31415980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.
    Nuti E; Cantelmo AR; Gallo C; Bruno A; Bassani B; Camodeca C; Tuccinardi T; Vera L; Orlandini E; Nencetti S; Stura EA; Martinelli A; Dive V; Albini A; Rossello A
    J Med Chem; 2015 Sep; 58(18):7224-40. PubMed ID: 26263024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress towards water-soluble triazole-based selective MMP-2 inhibitors.
    Fabre B; Filipiak K; Zapico JM; Díaz N; Carbajo RJ; Schott AK; Martínez-Alcázar MP; Suárez D; Pineda-Lucena A; Ramos A; de Pascual-Teresa B
    Org Biomol Chem; 2013 Oct; 11(38):6623-41. PubMed ID: 23989288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis.
    Ayoup MS; Fouad MA; Abdel-Hamid H; Ramadan ES; Abu-Serie MM; Noby A; Teleb M
    Eur J Med Chem; 2020 Jan; 186():111875. PubMed ID: 31740054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pentanoic acid derivative targeting matrix metalloproteinase-2 (MMP-2) induces apoptosis in a chronic myeloid leukemia cell line.
    Mukherjee A; Adhikari N; Jha T
    Eur J Med Chem; 2017 Dec; 141():37-50. PubMed ID: 29028530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAF(V600E) inhibitors.
    Wang SF; Zhu YL; Zhu PT; Makawana JA; Zhang YL; Zhao MY; Lv PC; Zhu HL
    Bioorg Med Chem; 2014 Nov; 22(21):6201-8. PubMed ID: 25267006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular Carcinoma.
    Khalil HH; Osman HA; Teleb M; Darwish AI; Abu-Serie MM; Khattab SN; Haiba NS
    ChemMedChem; 2021 Dec; 16(24):3701-3719. PubMed ID: 34547831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New in Vivo Compatible Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitors.
    Beutel B; Song J; Konken CP; Korpos E; Schinor B; Gerwien H; Vidyadharan R; Burmeister M; Li L; Haufe G; Sorokin L
    Bioconjug Chem; 2018 Nov; 29(11):3715-3725. PubMed ID: 30277751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.